--- title: "Citius Pharma (CTXR.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/CTXR.US/norm.md" symbol: "CTXR.US" name: "Citius Pharma" parent: "https://longbridge.com/en/quote/CTXR.US.md" datetime: "2026-05-21T14:41:40.838Z" locales: - [en](https://longbridge.com/en/quote/CTXR.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/CTXR.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/CTXR.US/norm.md) --- # Citius Pharma (CTXR.US) — Financial Reports ## Income Statement (USD) | Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | EPS | -0.9500 | -0.3824 | -0.4628 | -0.7986 | -1.27 | | ROE | -120.03% | -44.58% | -48.02% | -55.93% | -69.27% | | Revenue | 1.67M | 3.94M | - | - | - | | Net income | -21.23M | -8.22M | -7.96M | -8.79M | -10.92M | | Operating income | -30.47M | -8.45M | -8.44M | -8.79M | -11.26M | | Gross margin | 80.27% | 79.99% | - | - | - | | Net margin | -1273.39% | -208.43% | - | - | - | | Profit quality | - | - | - | - | - | ## Balance Sheet (USD) | Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | A&L | 132.54M | 140.39M | 130.94M | 127.68M | 121.48M | | Leverage | 1.92 | 1.50 | 1.69 | 1.89 | 1.91 | | BVPS | 2.75 | 3.57 | 3.74 | 4.49 | 6.92 | | Turnover | 0.0442 | 0.0302 | - | - | - | | Cash & STI | 4.59M | 7.72M | 4.25M | 6.09M | 26410.00 | | Inv & Rec | 22.66M | 22.64M | 22.29M | 17.21M | 15.34M | | LT assets | 794518.00 | 835177.00 | 818694.00 | 880732.00 | 922099.00 | | Net debt | -3.78M | -5.89M | -2.44M | -4.21M | 905385.00 | ## Cash Flow Statement (USD) | Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | Operating CF | -1.30M | -13.01M | -11.88M | -5.41M | -4.54M | | Investing CF | -600000.00 | -4.40M | -5.75M | - | - | | Financing CF | -1.23M | 20.88M | 15.79M | 11.47M | 3.47M | | Free CF | 6.82M | -17.97M | -20.11M | -1.91M | -270664.00 | | OCF coverage | -130.00% | - | - | -1802.21% | - | | Repaid & issued | - | - | 0.0000 | 1.30M | - | | CapEx | - | - | - | - | - |